Aram Chung received his B.S. in Mechanical Engineering from Seoul National University (SNU) in 2006 and earned a Ph.D. in Mechanical Engineering from Cornell University in 2011. Between 2011 and 2013, he conducted postdoctoral studies in Bioengineering at the University of California, Los Angeles (UCLA). He later joined Rensselaer Polytechnic Institute (RPI) as an Assistant Professor in the Mechanical Engineering Department, and in 2017, he moved to the School of Biomedical Engineering at Korea University where he now serves as a Professor. His research pioneered the establishment of microfluidic platforms for immunotherapy, genome editing and cell engineering. He has also taken on a leadership role in technology entrepreneurship, founding a company (MxT Biotech) that commercializes intellectual property developed in his lab.

Among his many honors, he was a finalist for the SLAS Innovation Award in 2020 and received the Seok-Top Technology Award from KU in 2022 and 2023. Further accolades include the BioChip Journal Award in 2021, the KOSMBE Young Investigator Award in 2019, and the Early Career Award from the BioChip Society in 2018. He was honored with the KSEA Young Investigator Award in 2017 and the RPI Class of 1951 Outstanding Teaching Award in 2016. Additionally, he received the UCLA Chancellor's Award for Postdoctoral Research in 2013, along with the Grand Prize and the 1st Prize Poster Award at ASME-IMECE in 2010 and 2009, respectively. He also won the Samsung HumanTech Paper Silver Award in 2008.

Contact: ac467 at korea.ac.kr